Anaplasia and drug selection-independent overexpression of the multidrug resistance gene, MDR1, in Wilms' tumor

Modern Pathology

Volumn 10, Issue 2, 1997, Pages 129-136

  Re, Gian G ^a   Willingham, Mark C ^a   El Bahtimi, Reem ^a   Brownlee, Noel A ^a   Hazen Martin, Debra J ^a   Garvin, A Julian ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

anaplasia; multidrug resistance; p53; Wilms' tumor

Indexed keywords

ANTINEOPLASTIC AGENT; DAUNORUBICIN; GLYCOPROTEIN P; MESSENGER RNA; PROTEIN P53; VERAPAMIL;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER CELL CULTURE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIDRUG RESISTANCE; NEPHROBLASTOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING;

ANAPLASIA; ANTINEOPLASTIC AGENTS; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; P-GLYCOPROTEIN; WILMS TUMOR;

EID: 0031038584     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Green DM, Beckwith JB, Breslow NE, Faria P, Moksness J, Finklestein JZ, et al. Treatment of children with stages II to IV anaplastic Wilms' tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 1994;12:2126-213.
2. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 1990;60:509-20.
3. Haber DA, Housman DE. The genetics of Wilms' tumor. Adv Cancer Res 1992;59:41-68.
4. Bardeesy N, Falkoff DF, Petruzzi M-J, Nowak N, Zabel B, Adaw M, et al. J Anaplastic Wilms' tumor, a subtype displaying poor prognosis, harbors p53 gene mutations. Nature Genet 1994;7:91-7.
5. Malkin D, Sexsmith E, Yeger H, Williams BRG, Coppes M. Mutations of the p53 tumor suppressor gene occur infrequently in Wilms' tumor. Cancer Res 1994;54:2077-9.
6. Bardeesy N, Beckwith BJ, Pelletier J. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 1995;55:215-9.
7. El Bahtimi R, Hazen-Martin DJ, Re GG, Willingham MC, Garvin AJ. Immunophenotype, mRNA expression and gene structure of p53 in classical and anaplastic Wilms' tumors. Mod Pathol 1996;9:1-7.
8. Chin K-V, Ueda K, Pastan I, Gottesman MM. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 1992;255:459-62.
9. Nguyen KT, Liu B, Ueda K, Gottesman MM, Pastan I, Chin K-V. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants. Oncol Res 1994;6: 71-7.
10. Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci U S A 1987;84: 265-9.
11. Cordon-Cardo C, O'Brien JP, Casals D, Rittman-Grauer L, Biedler JL, Melamed MR, et al. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Proc Natl Acad Sci U S A 1989; 86:695-8.
12. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci U S A 1987;84:7735-8.
13. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai S-L, Godzar A, et al. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989;81:118-24.
14. Roninson IB, Chin JE, Choi K, Gros P, Housman DE, Fojo A, et al. Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells. Proc Natl Acad Sci U S A 1986;83:4538-42.
15. Haber DA, Park S, Maheswaran S, Englert C, Re GG, Hazen-Martin DJ, et al. WT1-mediated growth suppression of Wilms' tumor cells expressing a WT1 splicing variant. Science 1993;262:2057-9.
16. Nichols KE, Re GG, Yan YX, Garvin AJ, Haber DA. WT1 induces expression of the insulin-like growth factor 2 in Wilms' tumor cells. Cancer Res 1995;55:4540-3.
17. Hazen-Martin DJ, Re GG, Garvin AJ, Sens DA. Distinctive properties of an anaplastic Wilms' tumor and its associated epithelial cell line. Am J Pathol 1994;144:1023-34.
18. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenolchloroform extraction. Anal Biochem 1987;162:156-9.
19. Re GG, Antoun GR, Zipf TF. Modulation of a constitutive transcriptional block at exon-1 controls human c-myc oncogene expression. Oncogene 1006;5:1247-50.
20. Feinberg AP, Vogelstein BA. Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 1983;132:6-13.
21. Pastan I, Gottesman MM, Ueda K, Lovelace E, Rutherford AV, Willingham MC. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc Natl Acad Sci U S A 1988;85:4486-90.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
23. Shen D-W, Cardarelli C, Hwang J, Cornwell M, Richert N, Ishii S, et al. Multiple drug-resistant human KB carcinoma cells independently selected for high-level resistance to colchicine, adriamycin, or vinblastine show changes in expression of specific proteins. J Biol Chem 1986;261:7762-70.
24. Willingham MC, Cornwell MM, Cardarelli CO, Gottesman MM, Pastan I. Single cell analysis of daunomycin uptake and efflux in multidrug-resistant and sensitive KB cells: effects of verapamil and other drugs. Cancer Res 1986;46:5941-6.
25. Rutherford AV, Willingham MC. Ultrastructural localization of daunomycin in multidrug-resistant cultured cells with modulation of the multidrug transporter. J Histochem Cytochem 1993;41:1573-7.
26. Haldar S, Negrimi M, Monne M, Sabbioni S, Croce CM. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res 1994;54:2095-7.
27. Maheswaran S, Park S, Bernard A, Morris JF, Rauscher III FJ, Hill DE, et al. Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci U S A 1993;90: 5100-4.